covid-19 |
129 |
humans |
91 |
sars-cov-2 |
79 |
adult |
67 |
epidemiology |
65 |
male |
65 |
animals |
63 |
chinese |
62 |
mortality |
58 |
diabetes |
56 |
female |
54 |
apoptosis |
52 |
inflammation |
52 |
children |
51 |
aged |
44 |
interprofessional education |
44 |
middle aged |
43 |
cardiovascular disease |
42 |
obesity |
42 |
hong kong |
40 |
public health |
40 |
atrial fibrillation |
39 |
cancer |
39 |
covid-19 vaccine |
39 |
mice |
38 |
oxidative stress |
38 |
stroke |
38 |
medical sciences |
37 |
heart failure |
36 |
osteoporosis |
34 |
adiponectin |
33 |
cardiovascular diseases |
31 |
rats |
31 |
cohort studies |
30 |
hypertension |
30 |
nitric oxide |
30 |
bnt162b2 |
29 |
breast cancer |
29 |
coronavac |
29 |
diabetes mellitus |
29 |
myocardial infarction |
29 |
vaccine safety |
29 |
depression |
28 |
partnership model |
28 |
social interaction anxiety |
28 |
type 2 diabetes mellitus |
28 |
amino acid sequence |
27 |
atherosclerosis |
27 |
cells, cultured |
27 |
china |
27 |
covid-19 vaccines |
27 |
dementia |
27 |
meta-analysis |
27 |
reactive oxygen species |
27 |
cytokines |
26 |
insulin resistance |
26 |
type 2 diabetes |
26 |
cell line |
25 |
colorectal cancer |
25 |
molecular sequence data |
25 |
hepatocellular carcinoma |
24 |
innate immunity |
24 |
pharmacoepidemiology |
24 |
asthma |
23 |
risk factors |
23 |
biomarker |
22 |
blood pressure |
22 |
dose-response relationship, drug |
22 |
ischemic stroke |
22 |
infants |
21 |
pregnancy |
21 |
reactive oxygen species - metabolism |
21 |
sars-cov-2 infection |
21 |
school closure |
21 |
blotting, western |
20 |
cohort study |
20 |
lung cancer |
20 |
metformin |
20 |
safety |
20 |
vitamin d |
20 |
adolescent |
19 |
cholesterol |
19 |
machine learning |
19 |
sars |
19 |
secondary prevention |
19 |
alzheimer's disease |
18 |
angiogenesis |
18 |
biology |
18 |
inactivated vaccine |
18 |
macrophages |
18 |
primary care |
18 |
reverse transcriptase polymerase chain reaction |
18 |
rna, messenger - metabolism |
18 |
self-controlled case series |
18 |
signal transduction - drug effects |
18 |
traditional chinese medicine |
18 |
tuberculosis |
18 |
adipose tissue |
17 |
adolescents |
17 |
aspirin |
17 |
coronavirus |
17 |
endothelium |
17 |
health sciences |
17 |
insulin |
17 |
long covid |
17 |
systematic review |
17 |
adult learning principles |
16 |
aging |
16 |
bone mineral density |
16 |
bronchiectasis |
16 |
cell line, tumor |
16 |
child psychosocial problems |
16 |
collaborative practice |
16 |
cyclooxygenase |
16 |
endothelial cells |
16 |
evaluation |
16 |
gene expression |
16 |
genotype |
16 |
healthcare workers |
16 |
home confinement |
16 |
hospital policies |
16 |
immunohistochemistry |
16 |
metabolic syndrome |
16 |
multimorbidity |
16 |
perceived stress |
16 |
pharmacy and pharmacology environmental studies |
16 |
polymorphism, single nucleotide |
16 |
psychological wellbeing |
16 |
time factors |
16 |
toxicology and environmental safety |
16 |
warfarin |
16 |
adverse events |
15 |
amino acid substitution |
15 |
ampk |
15 |
apoptosis - drug effects |
15 |
base sequence |
15 |
biomarkers |
15 |
body mass index |
15 |
ehr |
15 |
endothelial function |
15 |
gut microbiota |
15 |
odds ratio |
15 |
rats, sprague-dawley |
15 |
signal transduction |
15 |
tissue distribution |
15 |
vaccine effectiveness |
15 |
aged, 80 and over |
14 |
algorithms |
14 |
autophagy |
14 |
bacteria |
14 |
calcium |
14 |
cell proliferation - drug effects |
14 |
colon cancer |
14 |
complications |
14 |
coronavirus infection |
14 |
health outcomes |
14 |
immunoglobulin |
14 |
incidence |
14 |
kinetics |
14 |
metabolism |
14 |
mice, inbred c57bl |
14 |
nf-κb |
14 |
prevalence |
14 |
protein structure, tertiary |
14 |
proteomics |
14 |
rheumatoid arthritis |
14 |
screen time |
14 |
sex difference |
14 |
validation |
14 |
antioxidants |
13 |
asian continental ancestry group |
13 |
bone density |
13 |
chemicals and cas registry numbers |
13 |
cigarette smoking |
13 |
lymphocyte subsets |
13 |
major adverse cardiovascular events |
13 |
mendelian randomization |
13 |
menopause |
13 |
molnupiravir |
13 |
nirmatrelvir-ritonavir |
13 |
osteoporotic fractures |
13 |
paediatrics |
13 |
polymerase chain reaction |
13 |
pulmonary delivery |
13 |
rna interference |
13 |
up-regulation |
13 |
adipokine |
12 |
all-cause mortality |
12 |
allergy |
12 |
animal experiment |
12 |
asia |
12 |
blotting, northern |
12 |
chinese medicine |
12 |
chronic diseases |
12 |
chronic liver disease |
12 |
cirrhosis |
12 |
convalescence |
12 |
diabetic cardiomyopathy |
12 |
electrophoresis, gel, two-dimensional |
12 |
endothelial dysfunction |
12 |
enzyme inhibitors - pharmacology |
12 |
enzyme-linked immunosorbent assay |
12 |
false positive |
12 |
fracture |
12 |
gene frequency |
12 |
health economics |
12 |
health services |
12 |
hip fractures |
12 |
hong kong - epidemiology |
12 |
hyperthyroidism |
12 |
hypothyroidism |
12 |
hypoxia |
12 |
kawasaki disease |
12 |
liver injury |
12 |
models, biological |
12 |
myocarditis |
12 |
non-communicable diseases |
12 |
obstructive sleep apnea |
12 |
pericarditis |
12 |
plasma |
12 |
prospective studies |
12 |
sars-cov-2 rbd igg |
12 |
serology |
12 |
stress |
12 |
t cell response |
12 |
asian continental ancestry group - genetics |
11 |
bmd |
11 |
ckd |
11 |
clinical vertebral fractures |
11 |
disease models, animal |
11 |
double-blind method |
11 |
effectiveness |
11 |
electronic health records |
11 |
graves disease |
11 |
hypersensitivity |
11 |
lipid |
11 |
lipids |
11 |
nanoparticles |
11 |
older adults |
11 |
omicron |
11 |
pharmacovigilance |
11 |
pharmacy |
11 |
pneumonia |
11 |
post-covid-19 syndrome |
11 |
proliferation |
11 |
prostaglandin e2 |
11 |
respiratory diseases |
11 |
sglt2 inhibitor |
11 |
statistics & research methods |
11 |
thyroid dysfunction |
11 |
thyroid function tests |
11 |
thyroid gland |
11 |
thyroiditis |
11 |
time in therapeutic range |
11 |
upper limb fractures |
11 |
vaccine |
11 |
5-fluorouracil |
10 |
adipocytes - metabolism |
10 |
adolescence |
10 |
all-cause pneumonia |
10 |
antidepressants |
10 |
antioxidants - pharmacology |
10 |
asparaginase |
10 |
attention-deficit/hyperactivity disorder |
10 |
autoimmune disorders |
10 |
beta-amyloid |
10 |
binding sites |
10 |
biological sciences |
10 |
bone density - genetics |
10 |
case-control studies |
10 |
catalase |
10 |
causality |
10 |
chronic kidney disease |
10 |
cigarette smoke |
10 |
comorbidity |
10 |
contraction |
10 |
cost-effectiveness |
10 |
cytokine |
10 |
delirium |
10 |
disease progression |
10 |
electronic health record |
10 |
electronic medical records |
10 |
endothelium-derived contracting factor |
10 |
enos |
10 |
enzyme activation - drug effects |
10 |
gastrointestinal haemorrhage |
10 |
gene expression regulation |
10 |
health equity |
10 |
herbal medicine |
10 |
herd immunity |
10 |
human leukocyte antigens |
10 |
incident cvd |
10 |
interleukin-6 |
10 |
interrupted time series |
10 |
interrupted time series analysis |
10 |
linkage disequilibrium |
10 |
lipocalin-2 |
10 |
mass spectrometry |
10 |
osteoarthritis |
10 |
oxidation-reduction |
10 |
oxidative stress - drug effects |
10 |
pasc |
10 |
pediatrics |
10 |
phospholipids |
10 |
phosphorylation - drug effects |
10 |
pneumococcal conjugate vaccines |
10 |
population-based electronic health records |
10 |
post-acute sequelae of sars-cov-2 |
10 |
post-covid cvd |
10 |
prescribing |
10 |
proteomics - methods |
10 |
real-world evidence |
10 |
risk factor |
10 |
saponin |
10 |
sequence alignment |
10 |
sirt1 |
10 |
statins |
10 |
telomere |
10 |
treatment outcome |
10 |
2-de |
9 |
a-fabp |
9 |
abdominal pain |
9 |
advanced glycation end-products |
9 |
adverse events of special interest (aesi) |
9 |
age-stratified |
9 |
animal cell |
9 |
antimicrobials |
9 |
association |
9 |
biological markers - blood |
9 |
body weight |
9 |
bone loss |
9 |
bradykinin |
9 |
cardiovascular complications |
9 |
cell membrane - metabolism |
9 |
cloning, molecular |
9 |
covid |
9 |
dna-binding proteins - genetics - metabolism |
9 |
down syndrome |
9 |
drug delivery |
9 |
drug utilization |
9 |
extraction |
9 |
follow-up studies |
9 |
genetics |
9 |
glycosylation |
9 |
green tea |
9 |
heart |
9 |
hela cells |
9 |
in situ hybridization |
9 |
infection |
9 |
intermittent hypoxia |
9 |
lipid metabolism |
9 |
lipoproteins |
9 |
liver |
9 |
liver - metabolism |
9 |
medicine |
9 |
mice, knockout |
9 |
microvascular complications |
9 |
mitochondria |
9 |
mutation |
9 |
nursing |
9 |
organic acid |
9 |
parkinson's disease |
9 |
polymorphism, genetic |
9 |
primary health care |
9 |
protein binding |
9 |
proteins - genetics |
9 |
regression analysis |
9 |
relaxation |
9 |
rna, messenger - analysis |
9 |
serotonin |
9 |
serum 25-hydroxyvitamin d |
9 |
spermatogenesis - physiology |
9 |
spray drying |
9 |
superoxide dismutase |
9 |
travel history |
9 |
undergraduate students |
9 |
vascular smooth muscle |
9 |
viral disease |
9 |
waning vaccine effectiveness |
9 |
wound healing |
9 |
adipocyte |
8 |
adipokines |
8 |
adiponectin receptor |
8 |
adverse events of special interest |
8 |
anoxia - metabolism |
8 |
anti-inflammatory agents - pharmacology |
8 |
antibiotics |
8 |
antimicrobial resistance |
8 |
antineoplastic activity |
8 |
antiresorptives |
8 |
antivirals |
8 |
anxiety disorder |
8 |
aorta |
8 |
apoptosis - drug effects - physiology |
8 |
appswe/ps1de9 |
8 |
aquaporin 9 |
8 |
aβ |
8 |
bacteremia |
8 |
bnt162b2 mrna covid-19 vaccines |
8 |
cdars |
8 |
child |
8 |
chinese population |
8 |
chronic disease |
8 |
clinical pharmacology |
8 |
cognitive impairments |
8 |
coronary artery disease |
8 |
cytotoxicity |
8 |
dabigatran |
8 |
diarrhoea |
8 |
dimerization |
8 |
drug regulatory |
8 |
emulated trial |
8 |
endothelium-dependent contractions |
8 |
endothelium-derived contracting factors |
8 |
endotoxemia |
8 |
epithelial cells |
8 |
escherichia coli |
8 |
family hardship |
8 |
fib-4 |
8 |
free radicals |
8 |
gastroenterology |
8 |
general practice |
8 |
genetic predisposition to disease |
8 |
glycolipids |
8 |
health disparity |
8 |
hemoglobin a1c |
8 |
hepatocytes - metabolism |
8 |
herbal medicines |
8 |
high-fat diet |
8 |
histamine |
8 |
hospitalisation |
8 |
hydrogen peroxide |
8 |
hypercholesterolemia |
8 |
hypercytokinemia |
8 |
hyperglycemia |
8 |
hypertriglyceridemia |
8 |
immunosuppression |
8 |
indirect effect |
8 |
influenza |
8 |
jak2/stat3 |
8 |
kir genetics |
8 |
latent class analysis |
8 |
meningitis |
8 |
metabolomic |
8 |
metalloporphyrins - pharmacology |
8 |
mitochondrial dysfunction |
8 |
mrna vaccine |
8 |
mutagenesis, site-directed |
8 |
myocardial ischemia injury |
8 |
neonates |
8 |
nested case-control study |
8 |
neuroinflammation |
8 |
nfs |
8 |
nitric oxide - metabolism |
8 |
nk cells |
8 |
observational study |
8 |
offspring |
8 |
orphan drug policy |
8 |
p53 |
8 |
paediatric gastroenterology |
8 |
patch-clamp techniques |
8 |
pediatric population |
8 |
pedigree |
8 |
pharmacokinetics |
8 |
pharmacology |
8 |
pi3k/akt |
8 |
polysaccharide |
8 |
polysaccharides |
8 |
preschooler |
8 |
prognosis |
8 |
proto-oncogene proteins c-akt - metabolism |
8 |
rare diseases |
8 |
recurrent cardiovascular events |
8 |
risk prediction score |
8 |
self-harm |
8 |
smoking |
8 |
sphingolipids |
8 |
testis - cytology - physiology |
8 |
therapeutics |
8 |
thiazolidinediones - therapeutic use |
8 |
transcription, genetic |
8 |
transfection |
8 |
translation to patients |
8 |
treatment access |
8 |
trs 2°p |
8 |
two-dimensional gel electrophoresis |
8 |
vaccine-related myocarditis |
8 |
vasoconstriction - drug effects |
8 |
vasodilation - drug effects - physiology |
8 |
zebrafish |
8 |
3t3 cells |
7 |
3t3-l1 cells |
7 |
acetic acid |
7 |
acetylcholine |
7 |
acetylcholine - pharmacology |
7 |
acrosome - physiology |
7 |
adenocarcinoma |
7 |
adipogenesis |
7 |
adrenergic beta-antagonists - pharmacology |
7 |
adverse drug reactions |
7 |
airway epithelial cells |
7 |
alcoholism |
7 |
alzheimer disease |
7 |
angiotensinconverting enzyme inhibitors |
7 |
antimicrobial stewardship |
7 |
antioxidant |
7 |
antipsychotics |
7 |
asians |
7 |
attention deficit hyperactivity disorder |
7 |
autism spectrum disorder |
7 |
bile acids |
7 |
binding, competitive |
7 |
bioactive compounds |
7 |
blood glucose - metabolism |
7 |
blood-brain barrier |
7 |
blood–brain barrier |
7 |
bmi |
7 |
bone metabolism |
7 |
c-reactive protein |
7 |
cancer-associated venous thrombosis (cat) |
7 |
carbapenemase-producing enterobacteriaceae |
7 |
carriage |
7 |
catalase - metabolism |
7 |
cattle |
7 |
cell fractionation |
7 |
cell proliferation |
7 |
cer1 |
7 |
colonoscopy |
7 |
coriolus versicolor |
7 |
covid-19 pandemic |
7 |
cross-sectional studies |
7 |
cyclooxygenase-2 |
7 |
dexamethasone - pharmacology |
7 |
dialysis patients |
7 |
differentiation |
7 |
direct oral anticoagulants (doacs) |
7 |
dpp4 inhibitor |
7 |
drug discovery |
7 |
drug modulation |
7 |
early childhood exposure |
7 |
early-life activities |
7 |
elderly |
7 |
elderly care |
7 |
endocrinology |
7 |
endothelial nitric oxide synthase |
7 |
endothelin-1 |
7 |
endothelium, vascular - drug effects - enzymology - physiology |
7 |
endothelium, vascular - drug effects - metabolism - physiology |
7 |
endothelium, vascular - drug effects - metabolism - physiopathology |
7 |
endothelium-derived hyperpolarizing factor |
7 |
family financial pressure |
7 |
fatty acid-binding proteins - blood |
7 |
forced expiratory volume - physiology |
7 |
gender |
7 |
gene expression - drug effects |
7 |
genetic correlation |
7 |
genetic vectors |
7 |
geriatrics |
7 |
gluconeogenesis |
7 |
glycated haemoglobin |
7 |
glycolysis |
7 |
guinea pigs |
7 |
haplotypes |
7 |
heat-shock proteins - metabolism |
7 |
homeostasis |
7 |
ht-29 cells |
7 |
hyperglycaemia |
7 |
hypoglycemic agents - therapeutic use |
7 |
in situ hybridization, fluorescence |
7 |
inducible nitric oxide synthase |
7 |
inhalation |
7 |
ischaemic stroke |
7 |
jnk |
7 |
jnk/c-jun signalling |
7 |
kidney |
7 |
left ventricular hypertrophy |
7 |
leguminosae |
7 |
lipocalin |
7 |
lipopolysaccharide |
7 |
liver cancer |
7 |
low-molecular-weight heparin (lmwh) |
7 |
lumbar disc degeneration |
7 |
macrophage polarization |
7 |
markov state-transition model |
7 |
medicine, chinese traditional |
7 |
mental disorders |
7 |
mice, inbred strains |
7 |
mmp-9 |
7 |
multiple reaction monitoring |
7 |
neuroprotection |
7 |
nf-kappa b - metabolism |
7 |
nfκb |
7 |
peritoneal dialysis |
7 |
phosphorylation |
7 |
phylogeny |
7 |
physical activity |
7 |
pleiotropy |
7 |
polygenic score |
7 |
polyphenols |
7 |
population aging |
7 |
population-based study |
7 |
ppar gamma - agonists - metabolism |
7 |
proanthocyanidins |
7 |
promoter regions, genetic |
7 |
promoter regions, genetic - genetics |
7 |
prostacyclin |
7 |
prostaglandin |
7 |
protein kinase c - metabolism |
7 |
proteins - genetics - metabolism |
7 |
proteome |
7 |
pseudomonas aeruginosa |
7 |
psychosocial development |
7 |
quality-adjusted life years (qalys) |
7 |
rat |
7 |
recombinant fusion proteins - metabolism |
7 |
recombinant proteins - metabolism |
7 |
renal replacement therapy |
7 |
resistance |
7 |
school closures |
7 |
school-aged children |
7 |
sequence analysis, dna |
7 |
sleep |
7 |
small interfering rna |
7 |
soluble guanylyl cyclase |
7 |
spermatozoa - cytology - metabolism |
7 |
substrate specificity |
7 |
survival |
7 |
tandem mass spectrometry |
7 |
thiazolidinediones |
7 |
tumor‐shrinking decoction |
7 |
ultra‐pressure liquid chromatography coupled tandem mass spectrometry |
7 |
vaccination |
7 |
vasoconstriction |
7 |
vasodilatation |
7 |
vasodilation |
7 |
vasodilation - drug effects |
7 |
vasodilator agents - pharmacology |
7 |
visceral fat |
7 |
visit‐to‐visit variability |
7 |
vital capacity |
7 |
waist circumference |
7 |
warburg effect |
7 |
zinc fingers |
7 |
25(oh)d |
6 |
acyl coenzyme a - metabolism |
6 |
adaptor protein |
6 |
adaptor proteins, signal transducing - genetics - metabolism |
6 |
adhd |
6 |
adiponectin - genetics |
6 |
adiponectin - metabolism |
6 |
adipose tissue - chemistry |
6 |
adiposity - physiology |
6 |
administration, inhalation |
6 |
adverse drug reaction |
6 |
age |
6 |
age factors |
6 |
allele |
6 |
anaphylaxis |
6 |
angiotensin ii |
6 |
angiotensin receptor blockers |
6 |
angiotensin-converting enzyme inhibitors |
6 |
anti-coagulant |
6 |
anti-inflammation |
6 |
anticoagulant |
6 |
antiepileptics |
6 |
anxiety |
6 |
appl1 |
6 |
arginine methylation |
6 |
biogenesis |
6 |
bioinformatics |
6 |
biological markers - analysis |
6 |
biotin |
6 |
bleeding |
6 |
blood glucose - analysis |
6 |
bone mineral testing |
6 |
bone turnover markers |
6 |
bronchial epithelial cells |
6 |
bronchiectasis - metabolism |
6 |
burden of disease |
6 |
c-reactive protein - analysis |
6 |
camp |
6 |
cancer metabolism |
6 |
cancer therapy |
6 |
cardiovascular event |
6 |
cardiovascular mortality |
6 |
carotid artery |
6 |
carotid intima-media thickness |
6 |
cell density |
6 |
challenge |
6 |
chemical constituent |
6 |
chemotherapy |
6 |
child, preschool |
6 |
chronic obstructive pulmonary disease |
6 |
cilia |
6 |
ciliary central microtubular orientation |
6 |
collagen |
6 |
controlled study |
6 |
copd |
6 |
covid-19 incidence |
6 |
cox regression |
6 |
curcumin |
6 |
cvd |
6 |
cyclic amp - metabolism |
6 |
cyp2c9 |
6 |
cytokines - genetics |
6 |
cytotoxic activity |
6 |
data repository |
6 |
depolarization |
6 |
diabetes mellitus, type 2 - blood - drug therapy |
6 |
dipeptidyl peptidase-4 inhibitors |
6 |
disease and disorders of/related to bone |
6 |
dna, complementary - genetics |
6 |
doac |
6 |
drug |
6 |
drug interactions |
6 |
drug safety |
6 |
dry powder inhaler |
6 |
efficacy |
6 |
electrophysiology |
6 |
endothelial progenitor cells |
6 |
endothelial senescence |
6 |
endothelium, vascular - metabolism |
6 |
endothelium, vascular - physiology |
6 |
energy metabolism |
6 |
ep4 |
6 |
epidemiological studies |
6 |
erxian decoction |
6 |
erythrocytes - enzymology |
6 |
escherichia coli - genetics |
6 |
esophageal cancer |
6 |
estrogen receptor |
6 |
exercise |
6 |
fatty liver |
6 |
fracture prevention |
6 |
fractures, bone - genetics |
6 |
ganoderma lucidum |
6 |
gastrointestinal bleeding |
6 |
gastrointestinal tumours |
6 |
gc gene |
6 |
gene |
6 |
gene expression profiling - methods |
6 |
general diabetes |
6 |
general population studies |
6 |
genetic association |
6 |
genetic disease |
6 |
genistein |
6 |
genome-wide association study |
6 |
genome-wide haplotype association mapping (ham) |
6 |
genomics |
6 |
gleditsia sinensis |
6 |
glucocorticoid receptor |
6 |
glucocorticoids |
6 |
glucose intolerance - blood - genetics |
6 |
glutathione peroxidase |
6 |
glyburide - therapeutic use |
6 |
glycemic control |
6 |
hdl‐c |
6 |
health policy |
6 |
healthcare resource |
6 |
heme oxygenase-1 |
6 |
herb-drug interaction |
6 |
human |
6 |
hydrogen-ion concentration |
6 |
hypertension - epidemiology |
6 |
hypertriglyceridemia - epidemiology |
6 |
igt |
6 |
impaired glucose tolerance |
6 |
infant, newborn |
6 |
inflammatory bowel disease |
6 |
intellectual disability |
6 |
intensive care unit |
6 |
interleukin-6 - biosynthesis |
6 |
interstitial lung disease |
6 |
intestinal mucositis |
6 |
intra-abdominal fat |
6 |
intracranial hemorrhage |
6 |
intubation |
6 |
isoproterenol |
6 |
japan |
6 |
ldl‐c |
6 |
leucine |
6 |
likelihood functions |
6 |
lipids variability |
6 |
lithium |
6 |
lkb1 |
6 |
membrane proteins - biosynthesis |
6 |
messenger rna |
6 |
meta-data |
6 |
metabolic syndrome x - blood - epidemiology - etiology |
6 |
metabolomics |
6 |
metastasis |
6 |
methylphenidate |
6 |
mice, obese |
6 |
microarray |
6 |
mineral metabolism |
6 |
muscle contraction - drug effects |
6 |
muscle relaxation - drug effects |
6 |
muscle, smooth, vascular - drug effects - metabolism |
6 |
nafld |
6 |
nanotechnology |
6 |
neurogen |
6 |
neuroleptic agent |
6 |
neurological and mental health global epidemiology network |
6 |
non-alcoholic steatohepatitis |
6 |
non-st elevated myocardial infarction |
6 |
non-steroidal anti-inflammatory drugs |
6 |
norepinephrine - pharmacology |
6 |
nsaids |
6 |
obesity - epidemiology |
6 |
obesity - genetics |
6 |
oral anticoagulant |
6 |
organ culture techniques |
6 |
osteoblasts - metabolism |
6 |
osteoporosis - genetics - metabolism |
6 |
p-pkb |
6 |
paediatric |
6 |
panax notoginseng |
6 |
personalized medicine |
6 |
ph domain and leucine zipper containing 1 (appl1) |
6 |
phosphotyrosine interaction |
6 |
photodynamic therapy |
6 |
phytotherapy |
6 |
pkm2 |
6 |
pneumonia admission |
6 |
pomegranate peel ellagitannins |
6 |
preventive medicine |
6 |
prmt6 |
6 |
protein kinase c |
6 |
proteins - metabolism |
6 |
proto-oncogene proteins - genetics - metabolism |
6 |
psychological symptoms |
6 |
pulmonary hypertension |
6 |
quality of life |
6 |
radioimmunoassay |
6 |
rage |
6 |
rats, inbred shr |
6 |
rats, inbred wky |
6 |
rats, wistar |
6 |
receptors, immunologic - blood - drug effects |
6 |
reference values |
6 |
renin |
6 |
respiratory tract infections |
6 |
retrospective cohort |
6 |
retrospective studies |
6 |
rhinitis |
6 |
rickets |
6 |
rna, messenger - biosynthesis |
6 |
rosiglitazone |
6 |
salvia miltiorrhiza |
6 |
saponins - pharmacology |
6 |
sensitivity and specificity |
6 |
sequence homology, amino acid |
6 |
single-nucleotide polymorphism |
6 |
sleep apnea, obstructive - metabolism |
6 |
snoring |
6 |
sodium-glucose co-transporter |
6 |
sodium-glucose cotransporter-2 inhibitors |
6 |
soluble receptor for advanced glycation end-products |
6 |
southern chinese women |
6 |
spontaneously hypertensive rats |
6 |
st segment elevation myocardial infarction |
6 |
stability |
6 |
statin |
6 |
steroidogenic |
6 |
stomach |
6 |
stomach cancer |
6 |
structural identification |
6 |
structure-activity relationship |
6 |
suicide |
6 |
superoxide dismutase - metabolism |
6 |
supplementation |
6 |
swine |
6 |
telomere length |
6 |
thiazolidinedione |
6 |
timi grading system |
6 |
timosaponin aiii |
6 |
tnf receptor-associated factor 6 - genetics - metabolism |
6 |
toxicity |
6 |
tp receptors |
6 |
transcription factor gata 2 |
6 |
transmission electronic microscopy |
6 |
tumor necrosis factor-α |
6 |
type 1 diabetes |
6 |
ubiquitination |
6 |
umbilical veins |
6 |
uncaria rhynchophylla |
6 |
variability |
6 |
vdr gene |
6 |
vitamin d-binding protein |
6 |
17β-estradiol |
5 |
5-hydroxytryptamine |
5 |
action potentials - drug effects |
5 |
adaptor proteins, signal transducing - antagonists and inhibitors - genetics - physiology |
5 |
adaptor proteins, signal transducing - metabolism |
5 |
adenine - analogs and derivatives - metabolism - pharmacology |
5 |
adenoviridae - genetics |
5 |
adipocyte fatty-acid-binding protein |
5 |
adiponectin - biosynthesis - metabolism |
5 |
adiponectin - blood - genetics - metabolism |
5 |
adiponectin - deficiency - therapeutic use |
5 |
adiponectin and adipokine |
5 |
adipose tissue - drug effects - metabolism |
5 |
adult cardiology |
5 |
adulthood |
5 |
adverse drug event |
5 |
aerosol |
5 |
affinity chromatography |
5 |
ageing |
5 |
aging - metabolism |
5 |
agranulocytosis |
5 |
alleles |
5 |
alzheimer’s disease |
5 |
amp-activated protein kinases - metabolism |
5 |
analgesia |
5 |
andrographolide derivative |
5 |
androstadienes - administration & dosage |
5 |
anesthesia |
5 |
anti-inflammatory |
5 |
anticoagulation |
5 |
antidepressant |
5 |
antifungal |
5 |
antineoplastic agents - pharmacology |
5 |
antiplatelets |
5 |
aorta, thoracic - drug effects - metabolism - physiopathology |
5 |
appl2 |
5 |
asian population |
5 |
association study |
5 |
atenolol - pharmacology |
5 |
avascular necrosis |
5 |
bacteriuria |
5 |
bdmards |
5 |
berberine |
5 |
bioaccumulation |
5 |
biofilm |
5 |
biofilms |
5 |
biomedicine |
5 |
biostatistics |
5 |
blood glucose |
5 |
blood glucose - drug effects |
5 |
blood pressure - drug effects |
5 |
bone density - genetics - physiology |
5 |
bronchiectasis - drug therapy |
5 |
burden projection |
5 |
caffeine |
5 |
calycosin |
5 |
cancer incidence |
5 |
cancer risk |
5 |
cancer stem cells |
5 |
carcinoma, hepatocellular - metabolism - pathology |
5 |
cardiac dysfunction |
5 |
cardio-renal metabolic syndrome |
5 |
cardiovascular disease risk |
5 |
cardiovascular safety of biologics |
5 |
carotid artery diseases - diagnosis |
5 |
carrier proteins - metabolism |
5 |
cell adhesion molecules |
5 |
cell aging - drug effects - physiology |
5 |
cell cycle proteins - metabolism |
5 |
cell movement - drug effects |
5 |
cell nucleus - metabolism |
5 |
chemoprevention |
5 |
child maltreatment |
5 |
chitosan |
5 |
cholesterol homeostasis |
5 |
chromatography, high pressure liquid |
5 |
chromosomes, human, pair 1 |
5 |
chromosomes, human, pair 11 |
5 |
chromosomes, human, pair 14 |
5 |
ciclosporin |
5 |
clinical outcomes |
5 |
clopidogrel |
5 |
coffee |
5 |
cognitive footprints |
5 |
cohort analysis |
5 |
colonic neoplasms |
5 |
comorbidities |
5 |
confirmatory factor analysis |
5 |
cord blood |
5 |
coronary heart disease |
5 |
coronary vessels - anatomy and histology - drug effects - metabolism |
5 |
cost |
5 |
cox-1 |
5 |
creb |
5 |
cyclooxygenase inhibitors - pharmacology |
5 |
cyp7a1 |
5 |
cytochrome 3a4 |
5 |
database |
5 |
depression-like behavior |
5 |
diabetes mellitus, type 2 - blood - drug therapy - metabolism |
5 |
diabetes mellitus, type 2 - enzymology |
5 |
dietary fats - administration & dosage |
5 |
direct oral anticoagulants |
5 |
donepezil |
5 |
down-regulation |
5 |
doxorubicin |
5 |
drug design |
5 |
drug escalation |
5 |
drug resistance, fungal |
5 |
drug synergism |
5 |
early warning system |
5 |